This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

Jim Cramer's 'Mad Money' Recap: What Ails the Market? Drug Stocks

The drug stocks are competing with the oil patch for the prize of the worst sector in the entire market, Cramer says.

Jim Cramer's 'Mad Money' Recap: Here's Where the Bear Tide Is Turning

When the facts change, investors need to change their minds, Cramer says.

Jim Cramer's Top Takeaways: ConAgra, Nike, Apple, Starbucks, Wells Fargo

Cramer says ConAgra is attractive at current levels, don't buy Wells Fargo all at once, and Nike, Apple and Starbucks show the Chinese consumer is alive and buying.

Jim Cramer's Top Takeaways: Apple, Brunswick, Halyard Health

Cramer says Apple is not for the squeamish thanks to China, Brunswick is more than just boats.

Jim Cramer's Top Takeaways: Apple, Diageo, Imax, Blue Buffalo, Freshpet, Brixmor

Cramer says Apple and Diageo are being tarnished by China while he wouldn't invest in Blue Buffalo or Freshpet unless they merged.

Jim Cramer's Top Takeaways: Sonic, Darden, Fitbit, Johnson Controls

Cramer says Fitbit is a real company with real earnings and a bargain despite the big rally in the stock.

Jim Cramer's Top Takeaways: BioMarin, Radius Health, Allergan, Diageo, Wayfair

Cramer says BioMarin, Radius Health and Allergan are winners but stay away from Diageo.

Jim Cramer's Top Takeaways: Palo Alto Networks, Tesla, Ambarella, Allergan, Wingstop, Alkermes

Cramer says Allergan dominates treatments for your face with its buy of Kythera Biopharmaceuticals but it's time to ring the register on newly public Wingstop.

Jim Cramer's Top Takeaways: Verizon, Yahoo!, Horizon Pharma, Apple,, Dun & Bradstreet

Why shouldn't Verizon buy Yahoo!? Cramer asks. He also likes the technical indicators for Apple and

Jim Cramer's Top Takeaways: CVS, Target, Twitter, Express Scripts

Cramer is frustrated Twitter is blowing an opportunity to change for the better but says you should buy, buy, buy Express Scripts.

Page 1 of 6
< Previous
Top Rated Stocks Top Rated Funds Top Rated ETFs